Franklin Graham says he won't endorse Trump in GOP primary race
window.loadAnvato({"mcp":"LIN","width":"100%","height":"100%","video":"8315305","autoplay":false,"expect_preroll":true,"pInstance":"p5","plugins":{"comscore":{"clientId":"6036439","c3":"thehill.com","version":"5.2.0","useDerivedMetadata":true,"mapping":{"c3":"thehill.com","ns_st_st":"hill","ns_st_pu":"Nexstar","ns_st_ge":"TheHill.com","cs_ucfr":""}},"dfp":{"adTagUrl":"h
Read MoreMore Oath Keepers found guilty of seditious conspiracy for role in Jan. 6
window.loadAnvato({"mcp":"LIN","width":"100%","height":"100%","video":"8327072","autoplay":false,"expect_preroll":true,"pInstance":"p3","plugins":{"comscore":{"clientId":"6036439","c3":"thehill.com","version":"5.2.0","useDerivedMetadata":true,"mapping":{"c3":"thehill.com","ns_st_st":"hill","ns_st_pu":"Nexstar","ns_st_ge":"TheHill.com","cs_ucfr":""}},"dfp":{"adTagUrl":"h
Read MoreFive things to know about Jeff Zients, who is in line to be Biden's next chief of staff
Jeff Zients, the former White House coronavirus response coordinator, is expected to become President Biden’s next chief of staff, replacing Ron Klain and entering the role as Biden readies for the 2024 presidential election cycle. Klain is expected to hand over the reins to Zeints, 56, sometime after the State of the Union address in February after two years in the position. The position of White House chief of staff, while seen as one of the most powerful jobs in Washington, does not require Senate confirmation. Here are fi
Read MoreComer asks Secret Service for visitor information from Biden's Delaware home
window.loadAnvato({"mcp":"LIN","width":"100%","height":"100%","video":"8326611","autoplay":false,"expect_preroll":true,"pInstance":"p5","plugins":{"comscore":{"clientId":"6036439","c3":"thehill.com","version":"5.2.0","useDerivedMetadata":true,"mapping":{"c3":"thehill.com","ns_st_st":"hill","ns_st_pu":"Nexstar","ns_st_ge":"Hill.TV","cs_ucfr":""}},"dfp":{"adTagUrl":"https
Read MoreFDA panel to consider annual COVID-19 vaccine shots
The Food and Drug Administration's (FDA) advisory panel on vaccines is set to consider an annual schedule for the coronavirus vaccine, akin to how flu vaccines are administered, when it meets this week. The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify and streamline the COVID-19 vaccination process, including the composition of coronavirus vaccines and the recommended scheduling for these shots. The rapid evolution of the SARS-CoV-2 virus, resulting in variants with an improved ability to escape
Read More